Detecting CH 4 is crucial in hydrogen and methane breath testing (HMBT) for identifying intestinal methanogen overgrowth (IMO ...
Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company with development efforts focused on rare diseases, today announced that results from its Phase 2 FIGHT DMD clinical trial were ...